AL 704Alternative Names: AL-704; ALS 022704; JNJ 54257099
Latest Information Update: 19 Jan 2016
At a glance
- Originator Medivir AB
- Developer Janssen Infectious Diseases BVBA
- Class Antivirals; Nucleosides
- Mechanism of Action Hepatitis C virus NS 5 protein inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Hepatitis C